Literature DB >> 22162059

Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Natalia M Moll1, Anna M Rietsch, Smitha Thomas, Amy J Ransohoff, Jar-Chi Lee, Robert Fox, Ansi Chang, Richard M Ransohoff, Elizabeth Fisher.   

Abstract

OBJECTIVE: The study was undertaken to determine the pathologic basis of subtle abnormalities in magnetization transfer ratio (MTR) and diffusion tensor imaging (DTI) parameters observed in normal-appearing white matter (NAWM) in multiple sclerosis brains.
METHODS: Brain tissues were obtained through a rapid postmortem protocol that included in situ magnetic resonance imaging (MRI). Four types of MRI-defined regions of interest (ROIs) were analyzed: (1) regions that were abnormal on all images (T2T1MTR lesions); (2) NAWM regions with slightly abnormal MTR located close to white matter lesions (sa-WM Close); (3) NAWM regions with slightly abnormal MTR located far from lesions (sa-WM Far); and (4) NAWM regions with normal MTR (NAWM). Immunohistochemical analysis for each ROI comprised immunostaining for myelin, axonal markers, activated microglia/macrophages, astrocytes, plasma proteins, and blood vessels.
RESULTS: Forty-eight ROIs from 4 secondary progressive MS brains were analyzed. sa-WM Close ROIs were associated with significantly more axonal swellings. There were more enlarged major histocompatibility complex II(+) microglia and macrophages detected in sa-WM Far, sa-WM Close, and T2T1MTR lesions than in NAWM. Across all ROIs, MTR and DTI measures were moderately correlated with myelin density, axonal area, and axonal counts. Excluding T2T1MTR lesions from analysis revealed that MTR and DTI measures in nonlesional white matter (WM) were correlated with activated microglia, but not with axonal or myelin integrity.
INTERPRETATION: The pathologic substrates for MRI abnormalities in NAWM vary based on distance from focal WM lesions. Close to WM lesions, axonal pathology and microglial activation may explain subtle MRI changes. Distant from lesions, microglial activation associated with proximity to cortical lesions might underlie MRI abnormalities.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22162059      PMCID: PMC3241216          DOI: 10.1002/ana.22521

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  48 in total

Review 1.  Multiple sclerosis.

Authors:  J H Noseworthy; C Lucchinetti; M Rodriguez; B G Weinshenker
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

2.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

Authors:  Lars Bö; Jeroen J G Geurts; Paul van der Valk; Chris Polman; Frederik Barkhof
Journal:  Arch Neurol       Date:  2007-01

3.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis.

Authors:  N Evangelou; D Konz; M M Esiri; S Smith; J Palace; P M Matthews
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

4.  Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.

Authors:  H Vrenken; J J G Geurts; D L Knol; C H Polman; J A Castelijns; P J W Pouwels; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

5.  Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.

Authors:  N Evangelou; D Konz; M M Esiri; S Smith; J Palace; P M Matthews
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

6.  In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis.

Authors:  M Rovaris; M Bozzali; G Santuccio; A Ghezzi; D Caputo; E Montanari; A Bertolotto; R Bergamaschi; R Capra; G Mancardi; V Martinelli; G Comi; M Filippi
Journal:  Brain       Date:  2001-12       Impact factor: 13.501

Review 7.  Pathological abnormalities in the normal-appearing white matter in multiple sclerosis.

Authors:  I V Allen; S McQuaid; M Mirakhur; G Nevin
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

Review 8.  MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS?

Authors:  G R Wayne Moore
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

9.  Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis.

Authors:  V L Stevenson; G J Parker; G J Barker; K Birnie; P S Tofts; D H Miller; A J Thompson
Journal:  J Neurol Sci       Date:  2000-09-15       Impact factor: 3.181

Review 10.  The role of MRI as a surrogate outcome measure in multiple sclerosis.

Authors:  H F McFarland; F Barkhof; J Antel; D H Miller
Journal:  Mult Scler       Date:  2002-02       Impact factor: 6.312

View more
  96 in total

1.  White and gray matter damage in primary progressive MS: The chicken or the egg?

Authors:  Benedetta Bodini; Declan Chard; Daniel R Altmann; Daniel Tozer; David H Miller; Alan J Thompson; Claudia Wheeler-Kingshott; Olga Ciccarelli
Journal:  Neurology       Date:  2015-12-16       Impact factor: 9.910

Review 2.  Current and new directions in MRI in multiple sclerosis.

Authors:  Eric C Klawiter
Journal:  Continuum (Minneap Minn)       Date:  2013-08

Review 3.  State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications.

Authors:  Magalie Viallon; Victor Cuvinciuc; Benedicte Delattre; Laura Merlini; Isabelle Barnaure-Nachbar; Seema Toso-Patel; Minerva Becker; Karl-Olof Lovblad; Sven Haller
Journal:  Neuroradiology       Date:  2015-04-10       Impact factor: 2.804

4.  Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.

Authors:  Michael Amann; Athina Papadopoulou; Michaela Andelova; Stefano Magon; Nicole Mueller-Lenke; Yvonne Naegelin; Christoph Stippich; Ernst Wilhelm Radue; Oliver Bieri; Ludwig Kappos; Till Sprenger
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

Review 5.  Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.

Authors:  Maria Pia Sormani; Matteo Pardini
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

6.  A Spatio-Temporal Model for Longitudinal Image-on-Image Regression.

Authors:  Arnab Hazra; Brian J Reich; Daniel S Reich; Russell T Shinohara; Ana-Maria Staicu
Journal:  Stat Biosci       Date:  2017-10-23

7.  More than memory impairment in voltage-gated potassium channel complex encephalopathy.

Authors:  B M Bettcher; J M Gelfand; S R Irani; J Neuhaus; S Forner; C P Hess; M D Geschwind
Journal:  Eur J Neurol       Date:  2014-07-01       Impact factor: 6.089

8.  Diffusion tensor MRI as a biomarker in axonal and myelin damage.

Authors:  Wint Yan Aung; Soe Mar; Tammie Ls Benzinger
Journal:  Imaging Med       Date:  2013-10-01

9.  Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.

Authors:  Adrienne N Dula; Lori R Arlinghaus; Richard D Dortch; Blake E Dewey; Jennifer G Whisenant; Gregory D Ayers; Thomas E Yankeelov; Seth A Smith
Journal:  Magn Reson Med       Date:  2012-08-20       Impact factor: 4.668

10.  A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.

Authors:  Benedetta Bodini; Mara Cercignani; Ahmed Toosy; Nicola De Stefano; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2013-04-24       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.